In 2023, Taiyen Biotech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Taiyen Biotech has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2023, the total operational greenhouse gas (GHG) emissions of Taiyen Biotech amounted to 25,456 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Taiyen Biotech increased by 0.53%, suggesting that the company faced challenges in reducing its emissions from its core operations.
In 2023, the total Scope 1 emissions of Taiyen Biotech were 24,563 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2022), Taiyen Biotech's Scope 1 emissions increased by 1.01%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
In 2023, Taiyen Biotech reported Scope 2 greenhouse gas (GHG) emissions of 893 tCOâ‚‚e without specifying the calculation method.
Compared to the previous year (2022), Taiyen Biotech's Scope 2 emissions (Unspecified Calculation Method) fell by 10.97% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
In 2023, Taiyen Biotech reported its Scope 2 emissions using an unspecified methodology.